Samatasvir

CAS No. 1312547-19-5

Samatasvir( ATOLIHZIXHZSBA-BTSKBWHGSA-N | IDX719 )

Catalog No. M28765 CAS No. 1312547-19-5

Samatasvir is a pan-genotypic inhibitor of the HCV non-structural protein 5A.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 198 In Stock
5MG 112 In Stock
10MG 186 In Stock
25MG 376 In Stock
50MG 619 In Stock
100MG 986 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Samatasvir
  • Note
    Research use only, not for human use.
  • Brief Description
    Samatasvir is a pan-genotypic inhibitor of the HCV non-structural protein 5A.
  • Description
    Samatasvir is a pan-genotypic inhibitor of the HCV non-structural protein 5A.
  • In Vitro
    Samatasvir (IDX719) retains full activity in the presence of HIV and hepatitis B virus (HBV) antivirals and is not cross-resistant with HCV protease, nucleotide, and nonnucleoside polymerase inhibitor classes.
  • In Vivo
    ——
  • Synonyms
    ATOLIHZIXHZSBA-BTSKBWHGSA-N | IDX719
  • Pathway
    Microbiology/Virology
  • Target
    HCV
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1312547-19-5
  • Formula Weight
    885.07
  • Molecular Formula
    C47H48N8O6S2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (56.49 mM)
  • SMILES
    COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1c1nc2ccc(cc2[nH]1)-c1csc2c(csc12)-c1ccc(cc1)-c1cnc([nH]1)[C@@H]1CCCN1C(=O)[C@H](NC(=O)OC)c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Casper DM, et al. Toward the development of a structurally novel class of chiral auxiliaries: diastereoselective aldol reactions of a (1R,2S)-ephedrine-based 3,4,5,6-tetrahydro-2H-1,3,4-oxadiazin-2-one. Org Lett. 2002 Oct 17;4(21):3739-42.
molnova catalog
related products
  • Chlorcyclizine

    CHLORCYCLIZINE is a histamine H1 antagonist and a potent hepatitis C virus (HCV) entry inhibitor.

  • Deleobuvir

    Deleobuvir (BI-207127, BI207127) is a potent, selective HCV NS5B polymerase inhibitor with IC50 of 50 nM against GT-1 HCV polymerase activity.

  • HCV-IN-31

    HCV-IN-31 is a HCV inhibitor with an EC50/EC95 of 15.7 μM.